Find a Doctor or Practice Location

You can also search for providers and practices at Penn Medicine Lancaster General Health or Princeton Health.

I am searching for a
Reset Form
Kumarasen Cooper, MD, MBChB, DPhil

Kumarasen Cooper, MD, MBChB, DPhil Physician

Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania

Dr. Cooper is employed by Penn Medicine.

Request a Callback
No Patient Satisfaction Reviews
Why not?

There is no publicly available rating for this medical professional for one of the following reasons:

  1. He or she is not employed by Penn Medicine.
  2. He or she does not see patients in a medical practice setting.
  3. He or she sees patients but has not yet received the minimum 30 patient satisfaction reviews in the past 12 months, ensuring that the rating is statistically reliable and a true reflection of patient satisfaction.

About Dr. Kumarasen Cooper

Recognized by Best Doctors in America 2017, 2018

Jan 1982-Dec 1989/Dec 1992-Mar 1999: Routine Post Mortem and Surgical Pathology including use of Electron Microscopy, Immunofluorescence, Frozen Sections and Immunohistochemistry

May 1999-present: Routine general Surgical pathology sign out

Clinical Specialties


  • Pathology and Laboratory Medicine

Programs & Centers:

Board Certification:

  • Medicine

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • eLAP Services
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Homestead Smart Health Plans
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Provider Partners Health Plan
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: University of Kwa-Zulu Natal
Residency: University of Kwa-Zula Nata


Arkadi M. Rywlin Pathology Slide Seminar Club, Local College of American Pathologists, National International Academy of Pathologists (United States-Canadian Division), International International Society for Gynaecological Pathologists, International Royal College of Pathologists, Local South Africa College of Medicine, National

Hospital Affiliation

Dr. Cooper is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.


Description of Research Expertise:

Jan 1990-1992: As an Oxford Nuffield Research Fellow I joined Professor J O'D McGee's research laboratory at the John Radcliffe Hospital in Oxford. Using nonisotopic in-situ hybridisation (NISH) I conducted studies on Human Papillomavirus (HPV) infection of the uterine cervix using neoplastic specimens of paraffin embedded archival material from South Africa and Oxford. This led to the sequencing of a new HPV type from South Africa. In addition a novel method to determine the physical state of HPV using NISH was also described using confirmatory Southern blotting techniques. This work comprised the DPhil thesis.

Jan 1993-Mar 1999: In Johannesburg, I set up a molecular pathology laboratory utilising DNA in situ hybridisation, immunohistochemistry and PCR technology. This was funded by the SAIMR, MRC and NCA. Staffed with two full time senior technologists and one scientist, residents and attendings were involved in translational research. See abstracts and publications). I also set up the use of PCR (as an MMed project) for the investigation of lymphomas using gene rearrangements. This is now used as a routine investigation in this department. PCR technology for the detection of mycobacteria and HHV-8 is used for both research and diagnosis in paraffin sections. Several collaborative studies have been conducted with groups in the UK and USA (see publications).

May 1999-Present: In Burlington, Vermont, the Division of Experimental Pathology was created under my headship with two PhD scientists and two technicians. Pathology attendings and residents use this facility to engage in translational research. Collaborative projects have also been developed with Gyn Oncology, Otolaryngology and the Vermont Cancer Center. Aspects of my own research in HPV-associated cervical neoplasia continue to be investigated in this laboratory. These efforts are funded by the Vermont Cancer Center and Fletcher Allen Health Care.

An HPV Working Group comprising experts from various areas was also conceived with the view to educating high school teachers and children about the potential consequences of cervical HPV infections. Programs and presentation packages have been distributed with an enthusiastic reception.

Selected Publications:

Bumrungthai S, Munjal K, Nandekar S, Cooper K, Ekalaksananan T, Pientong C and Evans MF: Epidermal Growth Factor Receptor Pathway Mutation and Expression Profiles in Cervical Squamous Cell Carcinoma: Therapeutic Implications. Journal of Translational Medicine 13 : 244,2015.

Chetty R, Cooper K and Gown A.: Leong's Manual for Diagnostic Antibodies Book 3rd edition : 2016 .

Munjal, K, Adamson, CS-C, Rajendran, V, Nakedkar, S, Cooper K: Human Papillomavirus Type Distribution in Invasive Cervical Cancers from Madhya Pradesh: Implications for Vaccination Programs in Central India International Journal of Gynecological Pathology 33 (5): 531-536,2014.

Santer JL, Kalof AN, Evans MF, Cooper K: Prospective Analysis of P16INK4a Immunoexpression and HPV type in Benign Cervical Biopsies Modern Pathology 27 (#1259): 305A,2014.

Reyes MC, Cooper K: Cervical cancer biopsy reporting: A review Indian Journal of Pathlology and Microbiology 57 (3): 364-368,2014.

Evans MF, Peng Z, Clark KM, Adamson CSC, Ma XJ, Wu X, Wang H, Luo Y, Cooper K: HPV E6/E7 RNA In Situ Hybridization Signal Patterns as Biomarkers on Three-Tier Cervical Intraepithelial Neioplasia Grade PLOS|ONE 9 : e91142,2014.

Reyes MC, Cooper K: An update on vulvar intraepithelial neoplasia: terminology and a practical approach to diagnosis Journal of Clinical Pathology 67 : 290-294,2014.

Santer JL, Kalof AN, Evans MF, Powlovich LM, Cooper K.: P16INK4a Immunoexpression as a Possible Predictor of Disease Progression in Squamous Cervical Dysplasia Modern Pathology 27 (1259): 304A,2014.

Gardner J-A, Tang M, Cooper K.: Cytogenetic and Histopathologic Correlation of Renal Epithelial Neoplasms Modern Pathology 27 (946): 230A,2014.

Tatsumi K, Adamson CS, Peng Z, evans MF, Cooper K: Human Papillomavirus in Oropharyngeal Squamous Cell Carcinomas in Vermont: 1989-2010 Modern Pathology 27 (1359): 330A,2014.

Academic Contact Info

HUP - Pathology and Laboratory Medicine
6.067 Founders
3400 Spruce Street

Philadelphia, PA 19104-4283
Phone: (215) 662-6538
Patient appointments: 800-789-7366 (PENN)